UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Problems and Challenges Associated with Renaming Non-alcoholic Fatty Liver Disease to Metabolic Associated Fatty Liver Disease

Infectious diseases & immunity (Online), 2023-07, Vol.3 (3), p.105-113

2023

Volltextzugriff (PDF)

Correlations of PSGL-1 VNTR polymorphism with the susceptibility to severe HFMD associated with EV-71 and the immune status after infection

Virology journal, 2024-08, Vol.21 (1), p.187-8

2024

Volltextzugriff (PDF)

iTRAQ-based quantitative proteomics analysis of the effect of ACT001 on non-alcoholic steatohepatitis in mice

Scientific reports, 2023-07, Vol.13 (1), p.11336-11336, Article 11336

2023

Volltextzugriff (PDF)

Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-acting antiviral treatment

BMC gastroenterology, 2023-04, Vol.23 (1), p.102-102, Article 102

2023

Volltextzugriff (PDF)

ACT001 Alleviates chronic kidney injury induced by a high-fat diet in mice through the GPR43/AMPK pathway

Lipids in health and disease, 2023-11, Vol.22 (1), p.1-198, Article 198

2023

Volltextzugriff (PDF)

Levels of HBV RNA in chronic HBV infected patients during first-line nucleos(t)ide analogues therapy

Infectious agents and cancer, 2022-12, Vol.17 (1), p.61-61, Article 61

2022

Volltextzugriff (PDF)

Epidemiological and clinical characteristics of bacteremic brucellosis

Journal of international medical research, 2020-07, Vol.48 (7), p.300060520936829-300060520936829

2020

Volltextzugriff (PDF)

Impact of metabolic dysfunction-associated steatotic liver disease on the efficacy of immunotherapy in patients with chronic hepatitis B-related hepatocellular carcinoma

Cancer biology & medicine, 2024-05, Vol.21 (9), p.1-13

2024

Volltextzugriff (PDF)

Unveiling global research trends and hotspots on mitochondria in NAFLD from 2000 to 2023: A bibliometric analysis

Immunity, Inflammation and Disease, 2024-03, Vol.12 (3), p.e1226-n/a

2024

Volltextzugriff (PDF)

Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry study

Chinese medical journal, 2023-02, Vol.136 (3), p.341-350

2023

Volltextzugriff (PDF)

A Novel Noninvasive Diagnostic Model of HBV-Related Inflammation in Chronic Hepatitis B Virus Infection Patients With Concurrent Nonalcoholic Fatty Liver Disease

Frontiers in medicine, 2022-03, Vol.9, p.862879-862879

2022

Volltextzugriff (PDF)

Clinical and histological features under different nomenclatures of fatty liver disease: NAFLD, MAFLD, MASLD and MetALD

Journal of hepatology, 2024-02, Vol.80 (2), p.e64-e66

2024

Volltextzugriff (PDF)

Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD

The Korean Journal of Internal Medicine, 2016, 31(3), , pp.479-487

2016

Volltextzugriff (PDF)

The effect of migration on vaccination dilemma in networked populations

Chaos, solitons and fractals, 2023-05, Vol.170, p.113411, Article 113411

2023

Volltextzugriff (PDF)

Expert Consensus on Diagnosis and Treatment of End-Stage Liver Disease Complicated with Infections

Infectious diseases & immunity (Online), 2022-07, Vol.2 (3), p.168-178

2022

Volltextzugriff (PDF)

Exploring the role of mitochondrial proteins SIRT5 and MRPL33 through Mendelian randomization in primary biliary cholangitis

Clinics and research in hepatology and gastroenterology, 2024-08, Vol.48 (7), p.102394, Article 102394

2024

Volltextzugriff (PDF)

Letter to the editor: Prediction of biochemical nonresolution in patients with chronic drug‐induced liver injury: A large multicenter study

Hepatology (Baltimore, Md.), 2022-07, Vol.76 (1), p.E13-E14

2022

Volltextzugriff (PDF)

Letter to the editor: Effect of diabetes medications and glycemic control on risk of HCC in patients with NAFLD

Hepatology (Baltimore, Md.), 2022-08, Vol.76 (2), p.E48-E49

2022

Volltextzugriff (PDF)

Letter: serum growth differentiation factor 15 predicts hepatocellular carcinoma occurrence after hepatitis C virus elimination

Alimentary pharmacology & therapeutics, 2022-04, Vol.55 (8), p.1059-1060

2022

Volltextzugriff (PDF)

Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder

Theranostics, 2020-01, Vol.10 (21), p.9702-9720

2020

Volltextzugriff (PDF)

Thyroid-stimulating hormone is associated with nonalcoholic steatohepatitis in patients with chronic hepatitis B

Medicine (Baltimore), 2019-11, Vol.98 (46), p.e17945-e17945

2019

Volltextzugriff (PDF)

Levels of HBV RNA in chronic HBV infected patients during first-line nucleoside analogues therapy

Infectious agents and cancer, 2022-12, Vol.17 (1)

2022

Volltextzugriff (PDF)

Clinical value of thyroid related hormones combined with neutrophil to lymphocyte ratio in patients with nonalcoholic fatty liver disease

Medicine (Baltimore), 2022-12, Vol.101 (51), p.e31978-e31978

2022

Volltextzugriff (PDF)

Evaluation of HBV serological markers in treatment-naïve HBV mono-infected patients and HBV-HIV co-infected patients

Virus research, 2020-12, Vol.290, p.198117-198117, Article 198117

2020

Volltextzugriff (PDF)

A novel model based on serum N‐glycan markers for evaluating stage of liver necroinflammation in treatment‐naïve chronic hepatitis B patients

Journal of medical virology, 2024-08, Vol.96 (8), p.e29863-n/a

2024

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(53)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Problems and Challenges Associated with Renaming Non-alcoholic Fatty Liver Disease to Metabolic Associated Fatty Liver Disease

Correlations of PSGL-1 VNTR polymorphism with the susceptibility to severe HFMD associated with EV-71 and the immune status after infection

iTRAQ-based quantitative proteomics analysis of the effect of ACT001 on non-alcoholic steatohepatitis in mice

Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-acting antiviral treatment

ACT001 Alleviates chronic kidney injury induced by a high-fat diet in mice through the GPR43/AMPK pathway

Levels of HBV RNA in chronic HBV infected patients during first-line nucleos(t)ide analogues therapy

Epidemiological and clinical characteristics of bacteremic brucellosis

Impact of metabolic dysfunction-associated steatotic liver disease on the efficacy of immunotherapy in patients with chronic hepatitis B-related hepatocellular carcinoma

Unveiling global research trends and hotspots on mitochondria in NAFLD from 2000 to 2023: A bibliometric analysis

Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry study

A Novel Noninvasive Diagnostic Model of HBV-Related Inflammation in Chronic Hepatitis B Virus Infection Patients With Concurrent Nonalcoholic Fatty Liver Disease

Clinical and histological features under different nomenclatures of fatty liver disease: NAFLD, MAFLD, MASLD and MetALD

Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD

The effect of migration on vaccination dilemma in networked populations

Expert Consensus on Diagnosis and Treatment of End-Stage Liver Disease Complicated with Infections

Exploring the role of mitochondrial proteins SIRT5 and MRPL33 through Mendelian randomization in primary biliary cholangitis

Letter to the editor: Prediction of biochemical nonresolution in patients with chronic drug‐induced liver injury: A large multicenter study

Letter to the editor: Effect of diabetes medications and glycemic control on risk of HCC in patients with NAFLD

Letter: serum growth differentiation factor 15 predicts hepatocellular carcinoma occurrence after hepatitis C virus elimination

Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder

Thyroid-stimulating hormone is associated with nonalcoholic steatohepatitis in patients with chronic hepatitis B

Levels of HBV RNA in chronic HBV infected patients during first-line nucleoside analogues therapy

Clinical value of thyroid related hormones combined with neutrophil to lymphocyte ratio in patients with nonalcoholic fatty liver disease

Evaluation of HBV serological markers in treatment-naïve HBV mono-infected patients and HBV-HIV co-infected patients

A novel model based on serum N‐glycan markers for evaluating stage of liver necroinflammation in treatment‐naïve chronic hepatitis B patients

Suchergebnisse filtern